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731Mechanistic elements and critical factors of cellular reprogrammingprobe CDy1 for their global gene expression analysis. Day-to-day comparison of differentially expressed genes showed highly
dynamic and transient gene expressions during reprogramming, which were largely distinct from those of fully-reprogrammed
cells. An unbiased analysis of functional regulation indicated robust modulation of concurrent programs at critical junctures.
Globally, transcriptional programs involved in cell proliferation, morphology and signal transduction were instantly triggered
as early as 3 days-post-infection to prepare the cell for reprogramming but became somewhat muted in the final iPS cells. On
the other hand, the highly coordinated metabolic reprogramming process was more gradually activated. Subsequent network
analysis of differentially expressed genes indicated PDGF-BB as a core player in reprogramming which was verified by our gain-
and loss-of-function experiments. As such, our study has revealed previously-unknown insights into the mechanisms of cellular
reprogramming.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Since the first report of induced pluripotent stem (iPS) cells
generated by the expression of four transcription factors
Oct4, Sox2, Klf4 and c-Myc (OSKM) in fibroblasts (Takahashi
and Yamanaka, 2006), there has been a variety of technical
improvements to generate iPS cells more efficiently. Different
combinations of reprogramming transcription factors or addi-
tion of synthetic chemicals that influence epigenetic regulation
and signaling pathways have been discovered to enhance the
reprogramming efficiency and quality of stem cells (Feng et
al., 2009b; Han et al., 2010; Lin et al., 2009). However, the
mechanism of reprogramming, especially at the early phases,
remains elusive. One of the reasons for the scant knowledge
about reprogrammingmechanisms is the very low efficiency of
reprogramming. Only a small number of cells, which is under-
going reprogramming, need to be isolated out of heterogeneous
cell populations for the analysis. Although the expression
of fluorescent proteins using Oct4 or Nanog promoters has
been used to detect and isolate mature iPS cells in 2–
4 weeks of time, there has been no efficient way to probe the
cells undergoing reprogramming at early phases. Profiling gene
expression patterns during reprogramming has previously
been attempted using unsorted mixed populations of second-
ary mouse embryonic fibroblasts (MEFs) harboring doxycycline-
inducible OSKM genes (Samavarchi-Tehrani et al., 2010) or
partially reprogrammed cell lines which were not actively
undergoing reprogramming (Mikkelsen et al., 2008). Recently,
Buganim et al. identified single cells which turn into iPS cells
and analyze expression profiles of 48 genes in those cells
(Buganim et al., 2012), while Polo et al. analyzed global gene
expression profiles of the cells enriched based on SSEA-1 and
Thy1 expressions (Polo et al., 2012) and Hansson et al. analyzed
proteome changes during reprogramming under dox-inducible
transgenic system (Hansson et al., 2012). The reprogramming
mechanisms newly revealed by these studies demonstrate the
necessity of more tools with which the rare cells undergoing
reprogramming can be isolated.
We previously reported a fluorescent chemical probe CDy1,
which selectively stains living embryonic stem (ES) cells of both
human and mouse origin and enables the isolation of ES cells
from a mixture with fibroblasts by fluorescence-activated cell
sorting (FACS) (Im et al., 2010; Kang et al., 2011). CDy1 detects
iPS cells as well, at both early and late phases of reprogramming
as demonstrated using the cells of a transgenic mouse that
express GFP under the control of Oct4 promoter. When the
mouse fibroblasts were transfected with retroviral vectorsencoding OSKM and then incubated with CDy1, some colonies
were brightly stained at 10 days post infection (dpi) before GFP
expression, which eventually turned into GFP-expressing
colonies at a later time. In another study, we demonstrat-
ed that CDy1 can be used as an iPS cell reporter even at
7 dpi in a high throughput screening of chemicals designed
for the development of reprogramming enhancer (Vendrell
et al., 2012). These findings led us to hypothesize that cells
undergoing reprogramming could be isolated at different time
points during reprogramming using CDy1 and their stepwise
global gene expression analysis would enable the identification
of key mechanisms, pathways or molecules that play important
roles in cellular reprogramming. Based on this hypothesis,
we identified differentially expressed genes (DEGs) in the
CDy1-positive cells harvested at several early time points of
reprogramming starting from as early as 3 dpi and analyzed
the data using various bioinformatics tools. A functional
transcriptomic analysis of the data revealed an unprece-
dented sequence of cellular mechanisms of reprogramming
and a DEG network analysis identified PDGF-BB as a critical
factor for the process.
Materials and methods
Cell culture
MEFs were cultured on gelatin-coated dish in high-glucose
Dulbecco's Modified Eagle's medium (DMEM) supplemented
with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin, 0.1 mM non-essential
amino acids and 0.1% β-mercaptoethanol. To be used as
feeder, the cells were treated with mitomycin C (10 μg/ml) for
2 h and washed with PBS. iPS cells were cultured on these
feeder cells in DMEM containing 20% knock-out serum
replacement (KOSR, Invitrogen), 1 mM L-glutamine, 0.1 mM
β-mercaptoethanol, 1% non-essential amino acids and
100 U/ml leukemia inhibitory factor (LIF, Chemicon).
iPS cell generation
MEFs prepared from B6;CBATg(Pou5f1-EGFP)2Mnn/J mouse
(Jackson Laboratory) were infected by pMX-Oct4, Sox2, Klf4
and c-Myc expressing retrovirus with 10 μg/ml polybrene
(Sigma) in normal MEF culture medium for 1 day and the
medium was replaced with iPS cell culture medium the next
day (1 dpi). At 2 dpi, the infected cells were seeded on
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well in 12-well plates. The medium was replaced daily and
Oct4-GFP positive colonies were counted from the fluores-
cence images taken at 24 dpi using an ImageXpressMICRO
system.
Fluorescence-activated cell sorting
Cells incubated with 100 nM of CDy1 for 1 h were washed
with PBS and harvested using trypsin-EDTA. Since unhealthy
and dead cells are non-selectively stained by CDy1, living
cells were gated based on side and forward scatter profiles
before collecting cells. At least 8 × 105 cells from the 7% of
living cells at the bright side of PE-Texas Red fluorescence
histogram were collected using FACS Aria™ (BD Biosciences).
For each reprogramming time point analyzed, 2 sets of cell
samples were collected from independent experiments.
DNA microarray profiling, pre-processing
and differential expression analysis
The total RNA was extracted from 8 × 105 cells/sample to
synthesize cRNA using an Illumina TotalPrep RNA amplifica-
tion kit. Purified and labeled cRNA was hybridized onto
MouseRef-8 v2 Expression BeadChips (Illumina) in duplicate
according to the manufacturer's instructions. The bead
intensities weremapped to gene information using BeadStudio
3.2 (Illumina), and underwent variance stabilizing transfor-
mation and robust spline normalization in the R's Lumi
package. Correlation scatter plots and hierarchical clustering
were done using GenPlex software package (Istech).
We used an online tool (Laing and Smith, 2010) based on the
rank product algorithm (Breitling et al., 2004) for differential
expression analysis of the microarray data. A major strength of
this approach is the lower number of replicates required for
similar false discovery rates, compared to analyses requiring
some variation of standard deviation computation. Importantly,
the algorithm requires a minimum of two replicates for the
q-value (corrected p-value) evaluation of transcript probe
compared to three replicates for approaches based on statis-
tical deviation computation. As such, we were able to use
q-value which is an objective and more reliable criterion in
short-listing genes for further analysis compared to the
commonly-used simple fold-change. Venn diagram analyses of
DEGs were done online (VENNY: http://bioinfogp.cnb.csic.es/
tools/venny/index.html).
Functional regulation based on enrichment analysis
Gene enrichment analysis based on the tool in the DAVID
database (Huang da et al., 2009) was conducted on DEGs to
shortlist interesting molecular and functional events from
both parental-MEF comparisons and sequential comparisons.
A modified Fisher's exact p-value (EASE score) of 1.0 is
assigned for under-representation of differentially-expressed
genes in gene groups. All gene groups with − log10 (modified
p-value) N2.0 for any early reprogramming days were pre-
liminarily shortlisted from KEGG's pathway, PANTHER's path-
way and GO's biological process (FAT) databases and then
assigned tomajor functional categories. Interesting functional
phenomena that were further studied typically had − log10(modified p-value) much greater than 2.0 for involved gene
groups and their analyses were exhaustively augmented with
knowledge on reprogramming biology. In the process, com-
plementary, synergistic and antagonistic gene groups are
also used to help understand the detailed mechanisms of
the broader function. In doing so, we used the enrichment
significance of a gene group as a numerical proxy for measuring
the corresponding functional regulation over time, providing
information on regulation onsets, time spans and maxima. By
combining usage of both parental-MEF and sequential compar-
isons in regulation study, we tracked changes from different
angles, both of which contributed understanding to the phy-
siological process of interest.
Functional regulation of major categories
To assess functional regulation of major functional categories,
memberships of participating gene groups were consolidated
and its enrichment of differentially-expressed genes was
recomputed using Fisher's exact test (http://www.langsrud.
com/fisher.htm) in a collated fashion.
Network analysis
The gene lists were uploaded to IPA database to overlay
eligible molecules onto a global molecular network devel-
oped from information contained in the Ingenuity Knowledge
Base. Networks of network eligible molecules were then
algorithmically generated based on their connectivity through
the use of IPA (Ingenuity® Systems, www.ingenuity.com).
Real time RT-PCR
The total RNA was extracted from 1 × 106 cells/sample using
RNeasy Mini Kit (QIAGEN) according to the manufacturer's
instruction. One-step quantitative RT-PCR was performed on a
StepOne™ Real-Time PCR System using a Power SYBR® Green
RNA-to-CT™ 1-Step Kit (Applied Biosystem). The relative mRNA
levels of the genes of interest were normalized to that of
GAPDH. The primer sequences used in this study are listed in
Supplementary Table 1.
PDGFR inhibitor and PDGF-BB antibody treatment
Various concentrations of AG 17 (Merck), AG 1295 (Merck),
AG 1296 (Merck) and Gleevec (Novartis) were added into
the medium from 3 dpi to 24 dpi. For PDGF neutralization
experiment, PDGF-BB antibody (Abcam) was added from 3 dpi
to 24 dpi.
In vitro differentiation of iPS cell
Embryoid bodies were generated by culturing iPS cells for
3 days in low-adherent dishes using a high-glucose DMEM
supplemented with 10% fetal calf serum, 2 mM L-glutamine,
100 U/ml penicillin, 100 μg/ml streptomycin, 0.1 mM non-
essential amino acids and 0.1% β-mercaptoethanol. Embry-
oid bodies were seeded on gelatin coated plates and further
cultured for 10 days for differentiation in the same media as
used for embryoid body generation.
Figure 1 Global gene expression profiles during reprogramming. (A): CDy1-stained distinct cell populations in OSKM-factor
transfected MEF were observed using fluorescence microscopy at 3, 5, 7 and 9 dpi of reprogramming. Left panels, bright field phase
contrast images; right panels, fluorescence images. CDy1-stained cells at 3 and 5 dpi are marked with white arrows. Scale bar,
100 μm. (B): The numbers of up- or down-regulated genes at each sample day at FDR ≤ 0.25 compared to the levels in fibroblast.
(C): Fold change profiles of 4 main gene clusters identified using K-median clustering with dot product metric. Total gene count is
greater than 1040 as a small number of genes had both up- and down- regulated transcript probes. (D): The number of genes whose
expression levels were regulated at FDR ≤ 0.25 compared to the levels in fibroblast during reprogramming and in final iPS cell.
(E): The number of genes whose expression levels were regulated at FDR ≤ 0.25 compared to the levels in fibroblast at specific
sampled days during reprogramming. (F): The number of genes whose expression levels were regulated at FDR ≤ 0.25 compared to
the levels at a prior time point. (G): The number of up- or down-regulated genes at each sample day at FDR ≤ 0.25 obtained using
prior time-point comparison. (H): Gene expression dynamics during reprogramming obtained by K-median clustering based on dot
product metric using prior time-point comparison.
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Cells prepared in PBS were injected subcutaneously into
the lower flanks of 8 weeks old SCID mice (3 × 106 cells
in 0.15 ml per site). Tumors grown under the skin were
excised 6–8 weeks after injection and fixed in 4% PFA
for paraffin embedding, sectioning and H&E staining. All
animal experiment procedures were performed in accor-
dance with a protocol approved by the Institutional Animal
Care and Use Committee.Results
Dynamic and transitional gene expression profile
during reprogramming
When the transfected MEFs were incubated with CDy1,
scattered single cells stained by CDy1 were observed as early
as at 3 dpi and morphologically distinguishable CDy1-stained
colonies appeared from 7 dpi (Fig. 1A), which started to
express GFP from 11 to 14 dpi (Supplementary Fig. S1A). We
734 S.-J. Park et al.collected the CDy1-stained brightest 7% of the cells, which
was the minimum amount for the global gene expression
analysis by DNA microarray, at 3, 5, 7 and 9 dpi using FACS.
The cells were further characterized by assessing the
expression of a pluripotent stem cell marker SSEA-1 and
the capability of iPS cell colony formation. The percentages
of SSEA-1+ cells determined by flow cytometry gradually
increased from 0.5% at 3 dpi to 1.7% at 9 dpi, which
corresponded to 7.1% and 24.3% of the collected CDy1bright
cells. Almost 100% of SSEA-1+ cells were identified as CDy1bright
cells at all time points (Supplementary Fig. S1B). The numbers
of iPS cell colonies generated from CDy1bright cells were
significantly larger (2.6–9.1 fold) than those from CDy1dim
cells at all time points (Supplementary Fig. S2). These results
suggest that CDy1 stains cells by detecting an earlier event in
reprogramming than SSEA-1 and Oct4 expressions.
Parental MEF, an established iPS cell line and a mouse
ES cell line were included as references. The lists of DEGs
during reprogramming were obtained by comparing the data
with that of MEF or prior time point cells using the rank
product algorithm. For further analyses, we identified
top-ranking DEGs using a false discovery rate (FDR) ≤0.25.
Although the FDR threshold seems low conventionally, we
noted that, with duplicates, we have rigorously controlled
false gene discoveries by judiciously applying the rank
product algorithm. The genes identified by the comparison
to the expression levels of MEF were found to be mainly
up-regulated during reprogramming and in the fully repro-
grammed iPS cells with up-regulated genes 5–16 times as
many as down-regulated ones (Fig. 1B), while similar ratios
between up- and down-regulated genes were shown when
identified by simple 2-fold change criteria (Supplementary
Fig. S3A). A K-median clustering with average dot-product as
metric identified 4 major regulation profiles which were
remarkably distinguishable by the intermediate and established
phases of reprogramming. They are: I) up-regulation during
reprogramming which then moderated in final iPS cell;
II) down-regulation during reprogramming which then also
moderated in final iPS cell; III) up-regulation in final iPS cell only
and; IV) down-regulation in final iPS cell only (Fig. 1C). Most
early responding genes as exemplified by clusters I and II
became mitigated in their regulation in final iPS cell, while
genes with more moderated differential expression during
reprogramming (clusters III and IV) tended to show greater fold
changes in final iPS cell. Remarkably, genes in clusters I and II
have highly similar kinetic profiles to that of Oct4, Sox2 and Klf4
transcription factors (Hansson et al., 2012), indicating that a
substantial proportion of these genes are immediate targets
of the factors. Interestingly, there were twice as many DEGs
during the reprogramming timeframe compared to the fully
reprogrammed cell (Fig. 1D). Furthermore, the expression of
regulated genes continuously evolved in a transient manner
during reprogramming. Specifically, only 35% (282/798) of DEGs
identified during reprogramming were common to all 4 sampled
days while another 30% (239/798) were highly specific to each
day (Fig. 1E), indicating a high turnover of sharply-regulated
genes.
With an eye for further elucidation of reprogramming
dynamics, we rationalized that comparison of expression
profiles to a prior time point i.e., 3 dpi vs. MEF, 5 dpi vs.
3 dpi, 7 dpi vs. 5 dpi, 9 dpi vs. 7 dpi and iPS cell vs. 9 dpi
should directly trace the evolution of expression changesduring reprogramming. This comparison revealed three
times as many DEGs as the comparisons to MEF (3194 vs.
1040) at the same FDR level of≤0.25 (Fig. 1F). Interestingly,
the numbers of DEGs at 5, 7 and 9 dpi were approximately 10
times larger than those identified by simple 2-fold change
criteria (Supplementary Fig. S3B). Notably, down-regulated
genes were comparable in numbers to up-regulated ones in
contrast to their relatively much smaller numbers from the
comparisons to MEF (Fig. 1G). We noted that the larger number
of transiently-regulated genes derived from prior-time-point
comparisons did not translate into similar number of
cumulatively-regulated genes from MEF comparisons for
two reasons. These transient genes were either (1) changing
expression level incrementally with a smaller fold-change or
(2) alternating between up and down-regulation day-to-day as
seen from multiple profiles of the K-means clustering result
(Fig. 1H). Importantly, the expression changes for these genes
are as significant (same FDR) (Supplementary Data 1), albeit
with a smaller fold-change. They could be thought of asmainly
providing an exploratory trajectory, in contrast to that of
the highly regulated genes determining transitory phenotypes
from MEF-comparisons. Secondly, we observed visually an
anti-correlation between early (3 dpi vs. MEF) and late ex-
pression changes (iPS vs. 9 dpi) for most genes, as depicted in
clusters I and II of Fig. 1H. This temporal switch-like-response
of the transcriptome (from negative to positive regulation and
vice-versa) was similarly observed earlier as the ‘drastic
resetting of the proteome’ (Hansson et al., 2012). Overall,
both our DEG clustering results for MEF and prior-time-point
comparisons also revealed that most regulatory changes
occurred either immediately following OSKM transfection
(≤3 dpi) or during late phase of reprogramming (after 9 dpi).Global analysis of cellular and molecular event
Functional enrichment analysis of DEGs is highly useful
revealing the repertoire of significant events spanning
various facets of the cell. Previous works by the others
have sought to describe the kinetic expression profiles of
selected functional genes or proteins during reprogramming.
Moving one step upstream, we adopted an unbiased approach
in evaluating global functional regulation by consolidating
the memberships of significant gene groups that are associat-
ed with DEGs (Supplementary Fig. S4). From our results, we
highlighted 4 major functional categories (Fig. 2) which showed
striking similarities to trends reported in earlier studies, thus
supporting their results. For example, genes with functions
related to proliferation (Mikkelsen et al., 2008), and proteins
related to morphology (and motility) (Hansson et al., 2012)
showed immediate and abrupt regulation at 3 dpi which
became mitigated in the fully-reprogrammed cells compared
to MEF. Interestingly, our analysis revealed a more moderated
increase in global metabolic regulation peaking at 9 dpi, which
is surprisingly consistent with the more gradual expression
of metabolic proteome (Hansson et al., 2012). More subtly,
we noticed a good degree of correlation between the
global proliferation and metabolism regulation profiles in
MEF-comparisons (Fig. 2), with 3 dpi as an exception where
the spike in proliferation regulation can be attributed to the
reactionary response of OSKM expression. Importantly, the
global signaling pathways were revealed for the first time to
Figure 2 Relative associations of DEGs with major functions
during reprogramming and in fully reprogrammed iPS cells. Left
panels, comparison to the levels in MEF; right panels, compar-
ison to the levels at the prior time point.
735Mechanistic elements and critical factors of cellular reprogrammingshow a similarly abrupt and transient regulation profile which
decreases significantly in the final iPS, underlying its impor-
tance as an early reprogramming mechanism.
Critical role of signaling in cell proliferation during
the early phase of reprogramming
One canonical theme behind reprogramming efficiency is
that rapid cell proliferation provides a key driving mecha-
nism in reprogramming (Kawamura et al., 2009; Utikal et al.,
2009). Due to the fundamental role of proliferation, we
characterized the function globally and further investigated
the molecular mechanisms for proliferation rate increase.
Growth factor-mediated signal transduction has been dem-
onstrated to be critical for cellular reprogramming as well as
for pluripotent stem cell maintenance and differentiation
(Miki et al., 2011; Silva et al., 2008; Wang et al., 2011). Our
analysis which revealed early significant activation of signaling-
related genes led us to hypothesize that signal transduction via
membrane receptors may be employed as an active mechanism
to initiate increased proliferation. We evaluated specific
examples of DEGs involved in signal transduction and found
the genes involved in various membrane receptor kinase
signaling such as Bmp4, Fgf7, Fgf10, Fgf13, Tgfb3, Tgfbr2,
Ltbp1, Ltbp3, and Pdgfra that are upstream of a similarly
more active MAPK pathway modulating cell proliferation
(Hoch and Soriano, 2003; Lanner and Rossant, 2010; Orford
and Scadden, 2008) (Fig. 3A; Supplementary Fig. S4). Asdeduced from the combined effect of c-Myc trans-activation
and increased signaling promoting mitogenesis, we found a
resulting greater than 9-fold increase in cyclin D expression
peaking at 7 dpi which drives resting fibroblasts through the
restriction point (R) as well as G1/S transition. Consequently,
these cells are likely to shorten their G1 gap phase as a first
step towards reprogramming.
However, oxidative stresses generated during increased
cell divisions can induce DNA damage and hence trigger
the P53 pathway, potentially limiting the proliferation and
reprogramming efficacy of aberrant cells. We found signif-
icant P53 pathway activity throughout early phases of
reprogramming (Fig. 3A) with responding genes to support
the notion of increased apoptotic sensitivity to DNA damage
and also increased cell cycle arrest-induced repair. This
include the activation of Cdkn1a, Cdkn2a, Trp53 identified
in earlier studies (Kawamura et al., 2009; Marion et al.,
2009; Mikkelsen et al., 2008; Utikal et al., 2009), and in
addition, we found Scotin, Thbs1, Fas and Gadd45b/g to
be similarly up-regulated. Accordingly, some cell cycle
facilitators such as Cdc2a, Ccnb1 and Cdk2 were found to
be down-regulated (Supplementary Fig. S4). It was unclear
earlier as to the specific mechanisms of how proliferating
cells are able to escape these anti-proliferation mechanisms
during reprogramming. However, from our expression analysis
of the control modules in the P53 pathway, the constitutive
increase in cyclin D and Mdm2 levels appears to be cornerstones
of increased proliferation, by bypassing cell cycle check-
points in successfully reprogramming cells (Figs. 3B and C).
For instance, due to the programs strongly driving cyclin D
production, it is likely that the increase in P16 (Cdkn2a
product) level could not effectively inhibit the mitogenic
activities of cyclin D/Cdk complexes while P21 (Cdkn1a
product) had a lesser propensity to induce cell cycle arrests
being sequestered by higher levels of the same cyclin D/Cdk
complexes. Similarly, high P53 and Arf (Cdkn2a product
variant) expressions were also countered by a higher level
of Mdm2 modulating P53 activation of cell cycle arrests,
senescence or apoptosis. Upon full reprogramming, cells were
released from stringent cell cycle checkpoints by the
repression removal of Cdkn1a and Cdkn2a expression,
while cell cycle facilitators such as Cdc2a and Ccnb1 were
re-expressed (Figs. 3B and C). Our analysis also showed
intense and rapid activation of hypoxia related genes at
early reprogramming phase (Fig. 3A; Supplementary Fig.
S4), which is in accordance with the finding that hypoxia
improves reprogramming efficiency (Yoshida et al., 2009).
Interestingly, most of these pathways became less signif-
icantly regulated in fully reprogrammed iPS cells. In all,
these results suggested that genes for acceleration as well
as inhibition of cell proliferation are both activated during the
early phase of reprogramming due to increased signaling as well
as proliferation-induced stresses. To this end, a switch-like
rewiring of global signaling pathways in reprogramming cells
compared to the final iPS cells was apparent from our analysis.Ordered metabolic gene expressions at late phase of
reprogramming
We reasoned that since a number of cell proliferation
related gene groups showed consistent regulations that
Figure 3 Transitional rewiring of global signaling network during early reprogramming. (A): Enrichment analysis reveals significant
regulation of signaling pathways with switch-like regulation behavior between the cells undergoing reprogramming and the final iPS
cell. (B): Diagram depicting molecular mechanisms involved in regulating proliferation by various pathways. It explains the effect of
key genes in the P53 pathway on proliferation. Blue boxes indicate Cdk activities during reprogramming while red boxes indicate Cdk
activities in both reprogramming and final iPS cells. (C): Key DEGs and control modules of the P53 pathway affect cell cycle
facilitation, cell cycle arrests as well as senescence & apoptotic sensitivity during reprogramming. ‘*’ and ‘**’ represent a change in
expression of at least two-folds and four-folds over MEF respectively. Although P53 pathway activators (Cdkn1a, Cdkn2a and Trp53)
undergo significant increase and some cell cycle facilitators (Ccnb1, Cdc2a and Cdk2) are down-regulated, the constitutive increase
in cyclin D and Mdm2 negates the effects of cell proliferation inhibitors in successfully reprogramming cells.
Figure 4 Regulation of ordered metabolic events. (A): Upper panel, solid line graphs depict significance of DEG regulation
association with proliferation function in epithelial cell (profile IV) and mammary gland epithelial cell (profile V) from the
comparisons to MEF, while three broken-lines from the comparisons to prior time-points describe similar DEG association with
proliferation in general (profile III), as well as epithelial cell (profile II) and mammary gland epithelial cell proliferation (profile I);
lower panel, DEG association with nutrient response functions. (B): Heat maps for the regulation of metabolism related functional
gene groups during reprogramming and iPS cells.
736 S.-J. Park et al.
737Mechanistic elements and critical factors of cellular reprogrammingwere in line with an increase in proliferation rate during the
early phase of reprogramming (Fig. 4A), a corresponding
metabolic profile peaking at a late phase should exist so as
to drive the biomass increase and higher energy require-
ments of accelerated proliferation. As expected, global
metabolic activity showed such an increase peaking at 9 dpi
(Fig. 4B). In further support of our view that molecular
mechanisms behind accelerated cell proliferation can be
deduced from regulation profiling, we found that the gene
group that enables cellular response to nutrient showed
significant and lasting increase in its activity (Fig. 4A)
between 3 and 9 dpi (DEG association peaked at 9 dpi, −
log p-values = 3.8). In providing an increase in sensitivity to
nutrient and subsequent uptake so as to support rapid cell
division and growth, it is an effective first indicator to
subsequent metabolic reprogramming. Interestingly, we also
detected significant activity of genes responding to nutrient
in the fully reprogrammed iPS cells (− log p-values = 2.4)
(Fig. 4A), which further attests to the differences in
metabolism between pluripotent stem cells and somatic
cells. Subsequent functional regulations represented a
constitutive spectrum of metabolic and other associated
processes. The first hint of positive nitrogen metabolism was
evident at 5 dpi and by 7 dpi when glucose metabolism,
phosphorus metabolism, biosynthetic and complex assembly
activities were triggered. At 9 dpi, energy metabolism was
highest with activated functions associated with oxidation
and reduction, generation of precursor metabolites and
energy, as well as glucose metabolic processes. For protein
synthesis-related metabolism, we found the earliest evi-
dence of activities at 9 dpi which included mRNA metabo-
lism, RNA processing, ribosome biogenesis, protein transport
and localization, as well as assemblies of macromolecular
complexes (Fig. 4B). Although the metabolism-related genes
remained significantly activated in final iPS cells after
reprogramming, their activities were much lower in com-
parison to 9 dpi suggesting higher proliferation potential of the
cells undergoing reprogramming compared to established iPS
cells.Critical role of PDGF-BB signaling
during reprogramming
In order to identify key candidate factors that highly
connected to DEGs, and such may influence reprogramming,
we further explored DEGs obtained using a FDR threshold
≤0.01 (Supplementary Fig. S4) by reconstructing their
temporal molecular networks using the Ingenuity Pathway
Analysis (IPA) tool with missing links filled up in the process.
We were particularly interested in signaling factors that
function from the extracellular space which can be readily
applied to cell culture system without genetic manipulation.
Among several networks, we noticed that TGF-β and PDGF-BB
appear commonly as central players in the networks which
showed high probability scores at every time point (Fig. 5).
As the role of TGF-β has already been well known as a
negative regulator in reprogramming (Ichida et al., 2009;
Maherali and Hochedlinger, 2009), we investigated the
effects of PDGF-BB during reprogramming. We first mea-
sured the expression levels of PDGF-A, -B and -C in CDy1bright
cells collected at 3, 5, 7 and 9 dpi by quantitative RT-PCR,which showed 7, 11, 58 and 67-fold increases of only
PDGF-B, respectively (Fig. 6A). To figure out the role of
exogenous PDGF-BB in reprogramming, we cultured OSKM-
transfected Oct4-GFP MEF in a medium containing 1 ng/ml
and 5 ng/ml of recombinant mouse PDGF-BB from the day
after plating (3 dpi) to 24 dpi. For a strict control of the
PDGF level in the medium, PDGF-free knock out serum
replacement (KOSR, Life Technologies) was substituted for
FBS. The number of GFP positive colonies counted at 24 dpi
in 1 ng/ml PDGF and 5 ng/ml PDGF-BB treated groups was
21 ± 4 and 15 ± 3 per well whereas only 7 ± 2 colonies were
observed in non-treated control wells (Fig. 6B). Because the
higher PDGF-BB concentration of 5 ng/ml did not further
increase the iPS cell colony numbers compared to 1 ng/ml,
PDGF-BB was applied at a concentration of 1 ng/ml in
the following experiments, which resulted in 3 to 6-fold
increases of iPS cell generation efficiency (Figs. 6B and C).
We were also able to detect significantly larger number of
CDy1-positive cells in PDGF-BB treated cells starting from
7 dpi (Supplementary Fig. S5). The critical role of PDGF-BB
in reprogramming was further confirmed by our finding that
PDGF receptor tyrosine kinase inhibitors such as AG 17, AG
1295, AG 1296 and Imatinib mesylate (Gleevec) as well
as a neutralizing antibody against PDGF-BB reduce the
reprogramming efficiency (Fig. 6D). We then fractionated
the PDGF-BB treatment time to determine at which time
points it enhances the reprogramming efficiency. Starting
from 3, 7, 11, 15 to 19 dpi, cells were treated with PDGF-BB
for four consecutive days and maintained in normal culture
medium until 24 dpi. The numbers of GFP positive colonies
in the wells treated with PDGF-BB from 3, 7, and 11 dpi
were over 2-fold higher than that of non-treated control,
while the cells treated from 15 to 19 dpi generated similar
numbers of colonies as the non-treated control (Fig. 6C). To
assess the effect of PDGF-BB on cell proliferation rate
during reprogramming we measured the size of iPS cell
colonies generated in the presence and absence of PDGF-BB
from 4 days before to 2 days after the expression of OCT4-GFP.
The growth rates of the 2 groups of iPS cell colonies were not
different (Supplementary Fig. S6). These results imply that
PDGF-BB exerts its effect at early phase of reprogramming
process and it is not simply due to enhanced cell proliferation.
We noted that Oct4 promoter activation, which we
employed as a mean for assessing reprogramming efficiency
in our study, may occur by other stimulations (Liedtke et al.,
2008). To verify that the OCT4-GFP positive cell colonies
grown in the medium containing PDGF-BB are iPS cells, we
stained them with CDy1 and then performed immunocyto-
chemistry with Nanog antibody. In both OCT4-GFP express-
ing cell colonies generated with and without PDGF-BB,
Nanog staining co-localized with CDy1 as well as with GFP
(Supplementary Fig. S7). Further, we randomly isolated 4
colonies and continuously passaged them for the assessment
of their stemness and pluripotency. The expression of SSEA-1
was visualized by immunocytochemistry (Supplementary Fig.
S8A), while the capability of differentiation into cell types of
all three germ layers was demonstrated by in vivo teratoma
assay (Supplementary Fig. S8B) as well as in vitro embryoid
body assay (Supplementary Fig. S8C). Increased expression
of endogenous OSKM factors and suppression of the exoge-
nously introduced factors were revealed by real time RT-PCR
(Supplementary Fig. S8D). We also found that the global
Figure 5 Network analysis with DEGs. Ingenuity Pathway Analysis networks revealed TGF-β (blue circle) and PDGF-BB (red circle)
as central players that link the DEGs with a FDR threshold of 0.01.
738 S.-J. Park et al.gene expression profile of a PDGF-BB assisted iPS cell line is
very similar to normal iPS and mES cell lines (Supplementary
Fig. S8E and S8F).
The results of all tests demonstrated that the four cell lines
are pluripotent stem cells. These results implied that the GFP
expression used as a surrogate marker for reprogramming in
our study is from iPS cells and the PDGF-BB treatment does not
affect the normal characteristics of iPS cells.Discussion
Through enrichment analysis as well as network analysis of
DEGs, we uncovered the critical role of PDGF-BB and identified
key mechanistic elements during the course of somatic cell
reprogramming to iPS cells. Our analysis demonstrates how a
large set of microarray data can be systematically analyzed
to profile global functional regulation in a biological system.
Instead of using the commonly-used fold-change, we opted to
undertake global gene analysis based on corrected p-values
and a corresponding FDR threshold of 0.25 in elucidating the
systems biology of reprogramming. Without further geneexpression validation, our threshold gives a good intuition of
their global validity i.e. 75% (1–0.25), as the DEG lists are
expected to have a fold-change magnitude greater than the
typical gene from comparison of random profiles and a
more direct translation of confidence than the common
fold-change magnitude.
Determining the context-specific functions of DEGs can be
challenging as individual gene analysis often results in many
irrelevant possibilities of high statistical significance without
further biological implication. On the other hand, the results
from enrichment analysis become increasingly obvious with
regard to biological significance when functionally-related
groups are clustered together, or interpreted in an integrated
context with other gene groups. Given that a biological function
is relevant in a specific context, the sequential enrichment
profile of associated gene groups can be an effective indicator
of temporal regulation. This approach is well suited to the
stepwise analysis of molecular and cellular events in processes
such as reprogramming.
The low efficiency of somatic cell reprogramming by
the expression of reprogramming factors delivered by viral
vectors may be attributed to variations in transfection
Figure 6 PDGF-BB enhances reprogramming efficiency. (A): PDGF-B gene expression levels during reprogramming measured by real
time RT-PCR. (B): Microscopy images and the numbers of GFP expressing colony generated in the presence of PDGF-BB. GFP positive
colonies in the wells treated with different concentrations of PDGF-BB were counted at 24 dpi. Data are presented as mean ± SD (n = 4).
(C): The effect of PDGF-BB treatment at different time points of iPS cell generation. GFP positive colonies were counted at 24 dpi. Data
are presented as mean ± SD (n = 4). (D): The effects of PDGFR inhibitors and PDGF antibody in reprogramming. Cells were treated from
3 dpi to 24 dpi. GFP positive colonies were counted at 24 dpi. Data are presented as mean ± SD (n = 4).
739Mechanistic elements and critical factors of cellular reprogrammingefficiency and transgene integration loci. Although the
reprogramming efficiency significantly improved by drug-
induced transgene expressions in genetically identical sec-
ondary MEF, it still remains as low as 4% (Wernig et al., 2008).
Stochastic processes governed by factors in epigenetic regula-
tion and cell division have been proposed to account for the
different responses of each somatic cell to the reprogramming
factors (Hanna et al., 2009). Despite the important role of
stochasticity in reprogramming, the highly transient expression
dynamics observed from our study are remarkably consistent
with the robust modulation of cellular functions at critical
time points. The response timings for each gene depend on its
specific multi-functional roles, and the combinatorial require-
ments of concurrent programs. Together, genes participating in
simultaneous programs may drive, coordinate, explore and
respond to the reprogramming landscape, all at the same time.
As such, gene expression involved can exhibit highly stochastic,
complex and yet robust dynamics. As an example to illustrate
the coordinated nature of reprogramming, we noted the
programs regulating signaling, adhesion, cytoskeleton
and extracellular matrix formation together with specific
proliferation-related ones are likely to be initially acti-
vated to reset the plasticity of the transcriptome andproteome (Hansson et al., 2012), in response to OSKM
activities. Subsequently, they are turned off and are
distinct from the global metabolism and proliferation
programs that become inbuilt later with the progression
of reprogramming. The delayed proliferation programs include
a rapid decline in cell size (Smith et al., 2010) and the distinct
expression patterns of cell-cycle proteins (Polo et al., 2012;
Ruiz et al., 2011).
PDGF has been well known to activate the PI3K/Akt
pathway (Franke et al., 1995) which is involved in the stemness
maintenance of both human and mouse ES cells (Armstrong et
al., 2006; Pebay et al., 2005; Watanabe et al., 2006; Wong et
al., 2007). Inhibition of PI3K/Akt pathway down-regulates
Nanog and its target genes such as Klf4, Tbx3, and Esrrb
(Storm et al., 2007, 2009) which are key factors required for
self-renewal of ES cells (Ivanova et al., 2006). The addition of
Tbx3 into the OSKM factors significantly improves the germ-line
transmission capacity of iPS cells (Han et al., 2010) and the
nuclear receptor Esrrb can substitute Klf4 in the induction of
iPS cells (Feng et al., 2009a). These facts suggest that the
effect of PDGF-induced PI3K/Akt signaling may bemultifaceted
in reprogramming. It is known that p53 suppression during
reprogramming increases the reprogramming efficiency in both
740 S.-J. Park et al.human and mouse cells (Hong et al., 2009; Kawamura
et al., 2009). Interestingly, we observed significant in-
crease in Mdm2 level during reprogramming which can
facilitate p53 degradation after its activation by PI3K/Akt
pathway (Mayo and Donner, 2001; Ogawara et al., 2002).
Hence, p53 suppression is another possible mechanism by
which PDGF increases the reprogramming efficiency. As such,
it is likely that signal transduction mediated by PI3K/AKT and
MAPK is one fundamental mechanism involved in the enhance-
ment of reprogramming efficiency by PDGF-BB.Conclusions
By employing a novel method for the isolation of cells at
early phases of reprogramming and taking a global perspec-
tive in interpretation of functional enrichment analysis, we
uncovered a repertoire of early events during the induction
of pluripotency and further identified PDGF-BB as a key
player during this time. The data presented in this study will
provide insight for the understanding of reprogramming
mechanisms yet to be elucidated.Acknowledgments
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